Free EMR Newsletter Want to receive the latest news on EMR, Meaningful Use, ARRA and Healthcare IT sent straight to your email? Join thousands of healthcare pros who subscribe to EMR and EHR for FREE!

$12.5 million raised for AssureRx Health, Startups Announced That Will Participate at Rock Health in Boston

Posted on June 11, 2012 I Written By

Katie Clark is originally from Colorado and currently lives in Utah with her husband and son. She writes primarily for Smart Phone Health Care, but contributes to several Health Care Scene blogs, including EMR Thoughts, EMR and EHR, and EMR and HIPAA. She enjoys learning about Health IT and mHealth, and finding ways to improve her own health along the way.

$12.5 million was recently raised in Series C financing by AssureRx Health Inc. AssureRx, a personalized medicine company, is an Ohio-based startup. The company is a personalized medicine company that specializes in pharmacogenomics and helps physicians figure out correct drugs for patients who suffer from neuropsychiatric and other related disorders.

Four Rivers Group, Claremont Creek Ventures, and Sequoia Capital led the financing; other investors that participated were Cincinnati Children’s Hospital Medical Center, Mayo Clinic, CincyTech, Allos Ventures, jVen Capital, and Alafi Capital. The funds that were raised will go toward increasing commercial activities for GeneSightRx® Psychotropic and GeneSightRx® ADHD, which are AssureRx’s two flagship pharmacogenomic products.

James S. Burns, president and CEO of AssureRx Health, described the company’s main objectives and what is expected to come from this round of funding:

Our goal is to build the leading clinical informatics company providing pharmacogenomic and other treatment decision support products to help physicians individualize the treatment of patients with neuropsychiatric and other disorderds. Proceeds from the Series C financing will be used to expand sales coverage, sponsor multiple clinical studies, and develop new products to help accelerate our leadership position in psychiatric personalized medicine.

Four Rivers, jVen Capital, and Alafi Capital, some of the investors in this Series C financing, bring along with their investments, connections to help build AssureRx Health’s leadership position in psychiatric pharmacogenomics.

New investors Four Rivers, jVen Capital, and Alafi Capital bring to AssureRx Health further expertise and partnering connections to help AssureRx Health continue building its leadership position in psychiatric pharmacogenomics.

In other news, Rock Health, a San Francisco-based digital health incubator, recently announced which six startups will be participating in the kick-off incubator in Boston this summer. Each of the startups participating will present on August 24th at a demo day. The startups that were selected for the Boston class are:

1. HomeTeam Therapy
2. PrescribableApps
3. NeuroTrack Technologies
4. Neumitra
5. NoviMedicine
6. ZeroSum Health

More information about Rock Health in Boston can be found here.

New App Allows For HIPAA-Compliant Group Texting by Clinicians

Posted on I Written By

Anne Zieger is veteran healthcare consultant and analyst with 20 years of industry experience. Zieger formerly served as editor-in-chief of and her commentaries have appeared in dozens of international business publications, including Forbes, Business Week and Information Week. She has also contributed content to hundreds of healthcare and health IT organizations, including several Fortune 500 companies. Contact her at @ziegerhealth on Twitter or visit her site at Zieger Healthcare.

John wrote previously on EMR and HIPAA about the need for HIPAA Secure Texting and a company he’s advising that does secure text messaging called docBeat.

Well, another new app called Medigram is being tested which will allow clinicians to send HIPAA-compliant text messages within a defined group. The app is currently in closed beta with docs at Stanford Hospital, Lucille Packard Children’s Hospital and the Palo Alto VA Hospital, according to

According to the company, Medigram meets not only HIPAA requirements but also privacy/security provisions in Subtitle D of HITECH.  It does so, in part, by using SSL connections between mobile apps and its servers, as well as NIST-approved 256-bit AES encryption to secure chat data.

Secure texting certainly seems like a good idea, given how mobile-friendly this generation of clinicians has turned out to be.  And it’s hard to argue Medigram’s core pitch, which is that texting is far more interactive than a pager. Given that a surprisingly large number of doctors still use pagers, improving on the model seems like a good thing.

My theory is that the app, if otherwise usable and bug-free, will be a big hit during its beta. If so, I expect to see HIPAA-compliant instant messaging turn up next. Smaller, presumably agile companies specializing in B2B messaging — such as HipChat, Trumpia and 24im — are logical candidates to develop such a utility. (This article outlines several other enterprise IM firms, just in case you want to dig deeper.)

Of course, there’s also Google and Microsoft, both of which have large IM bases. Perhaps creating a secure version of an existing product (such as Messenger) will be less of a marketing challenge than say, HealthVault.

Regardless, I’ll be quite interested to find out how the beta turns out — I’ll keep you posted. Meanwhile, here’s a video in which Medigram describes its product.